FDA posts docs for Radiesse panel; Israeli startup raises $5M for CHF monitor;

@FierceMedDev: ICYMI yesterday: In a medical first, three patients receive prosthetic hands in place of disabled ones. Article | Follow @FierceMedDev

@VarunSaxena2: Roche, BioMed X to jointly run diagnostics incubator in Germany. FierceDiagnostics story | Follow @VarunSaxena2

@EmilyWFierce: Cyberonics and Sorin to form U.K.-based company valued at $2.7B, aiming to boost hospital offerings. More from Bloomberg | Follow @EmilyWFierce

> Israeli startup Vectorious Medical Technologies has raised $5 million to develop its novel cardiac monitoring system for patients with congestive heart failure. More

> The FDA has posted documents for its Feb. 27 meeting of the General and Plastic Surgery Advisory Panel to assess Radiesse dermal filler for the hands from Merz. Documents

> Assisted reproduction embryo image assessment systems have been determined by the FDA to be class II devices. More

Biotech News

@FierceBiotech: After painful odyssey, Newron wins European OK for Parkinson's add-on. News | Follow @FierceBiotech

@JohnCFierce: Top story of the week: Exclusive: Pfizer is once again cutting back R&D staff in reorganization. Report | Follow @JohnCFierce

@DamianFierce: Hey so @FierceBiotech has a podcast now, and you can listen online and subscribe on iTunes. | Follow @DamianFierce

> Amgen completes PhIII trifecta as AMG416 goes head-to-head with Sensipar. Article

> Growing Dicerna moves into Cambridge supercluster. News

> Hospira and Celltrion hit a speed bump in their biosimilar dash. More

> Actavis wins FDA approval for a new 'superbug' antibiotic. Report

Pharma News

@FiercePharma: Deal-weighing Pharmacyclics could draw $18B from J&J, Novartis: Bloomberg. Report | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Sidelined after tampering incident, GSK's alli is back on sale. Report | Follow @CarlyHFierce

> SC's top court backs Risperdal verdict against J&J, but cuts penalty to $136M. Story

> Sanofi's fight for Toujeo market share won't be easy, analysts say. Article

Vaccines News

> NewLink nets $20M Ebola milestone from Merck. Item

> Valeant touts PhII Provenge data following Dendreon buy. More

> Takeda places vaccines unit in Singapore to push for global growth. Article

> Combo of Bavarian Nordic's Prostvac and BMS' Yervoy yields promising PhI results. Story

> Pfizer trumpets positive Trumenba data ahead of ACIP vote. Report

Pharma Manufacturing News

> Impax reports significant jump in revenues as it gets plant problems behind it. Report

> Unused Forest Labs facility snapped up by Aprecia Pharmaceuticals. News

> New Jersey compounder indicted over unsanitary manufacturing. Story

> Bharat, Serum Institute ramp up production of their swine flu vaccines. Item

> Federal judge cuts off Maine's Internet drug supply chain. Article

Suggested Articles

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.

Akoya Biosciences raised $50 million to help boost its commercialization in research, drug development and clinical testing markets.